dry eye
Conditions
Interventions
Instillation of 3% diquafosol sodium ophthalmic solution, 6 times daily for 4 weeks.
Sponsors
Minamiaoyama Eye Clinic Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: At time of informed consent 1) 20 years old and older. 2) Wearing contact lenses routinely. At time of starting administration 1) Diagnosed patients with dry eye or dry eye suspects based on dry eye diagnostic criteria (2006). 2) Patients with wearing 1 day acuvue moist; routinely for 1week or longer and complaining decreased visual performance.
Exclusion criteria
Exclusion criteria: 1) History of administered diquafosol sodium ophthalmic solution and/or rebamipide ophthalmic solution within one week before start of study. 2) Anatomically and/or functionally abnormal eyelid. (ex. eyelid closure abnormality) 3) History of ophthalmic surgery (including laser therapy) within 3 months before start of study. 4) History of occluding punctum. (ex. punctal plug or a punctal closing surgery) 5) Presence of a hypersensitivity to drugs scheduled to be used. (ex. diquafosol sodium, fluorescein, oxybuprocaine hydrochloride) 6) Presence of any other medical concern that may affect the accurate efficacy assessment or ensuring safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of visual function Change of subjective symptoms | — |
Countries
Japan
Outcome results
None listed